• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钌-106 和质子束放射治疗眼黑色素瘤后肿瘤周围正常视网膜的 OCT 变化。

OCT changes in peri-tumour normal retina following ruthenium-106 and proton beam radiotherapy for uveal melanoma.

机构信息

St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK

St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.

出版信息

Br J Ophthalmol. 2021 May;105(5):648-652. doi: 10.1136/bjophthalmol-2019-314802. Epub 2020 Jun 25.

DOI:10.1136/bjophthalmol-2019-314802
PMID:32586936
Abstract

INTRODUCTION

Uveal melanoma is most commonly treated with radiotherapy, destroying the tumour cells with adequate safety margins and limiting collateral damage to surrounding structures to preserve maximal vision. We used optical coherence tomography (OCT) to study the effects of radiotherapy on the retina.

METHODS

Patients with posteriorly located choroidal melanoma treated with proton beam radiotherapy (PBR) and ruthenium-106 brachytherapy between January 2010 and June 2014 underwent spectral domain OCT.

RESULTS

Images of 32 patients following ruthenium-106 brachytherapy and 44 patients following proton beam teletherapy were analysed. Following plaque brachytherapy, an early marked disruption of the outer retinal layers could be observed in 30 cases (94%) with retinal atrophy evident in 26 cases (81%). In contrast, the images from patients who underwent PBR showed subtle outer retinal layer change with 16 cases (36%) showing some inner-outer segment junction disruption by 6 months and 63%  by 24 months with minimal atrophy. In cases with tumours <2 mm from the fovea, the visual loss was significantly less at 6 and 12 months in the proton beam group.

CONCLUSION

In comparison to ruthenium-106 plaque brachytherapy, PBR leads to more subtle and slower changes in the outer retinal layers enabling retention of visual function for longer. The difference in dosing regime and dose distribution across the tumour is likely to be causative for this structural differential.

摘要

简介

葡萄膜黑色素瘤最常采用放射疗法治疗,通过在肿瘤细胞周围保留足够的安全边界,以限制对周围结构的附带损伤,从而达到消灭肿瘤细胞并保留最大视力的效果。我们使用光学相干断层扫描(OCT)来研究放射疗法对视网膜的影响。

方法

2010 年 1 月至 2014 年 6 月期间,我们对接受质子束放射疗法(PBR)和钌-106 近距离放射疗法治疗的、位于眼后段的脉络膜黑色素瘤患者进行了光谱域 OCT 检查。

结果

对 30 例(94%)接受钌-106 近距离放射治疗和 44 例(100%)接受质子束远距离放射治疗的患者的图像进行了分析。在接受敷贴器近距离放射治疗后,在 30 例(94%)患者中可以观察到早期明显的外视网膜层破坏,26 例(81%)患者出现明显的视网膜萎缩。相比之下,接受 PBR 的患者的图像显示外视网膜层的细微变化,16 例(36%)在 6 个月时出现一些内-外节连接中断,63%在 24 个月时出现中断,且萎缩程度最小。对于距黄斑<2mm 的肿瘤,在质子束组中,6 个月和 12 个月时的视力丧失明显较少。

结论

与钌-106 敷贴器近距离放射治疗相比,PBR 导致外视网膜层的变化更细微、更缓慢,从而使更长时间保留视觉功能。肿瘤内的剂量方案和剂量分布的差异可能是造成这种结构差异的原因。

相似文献

1
OCT changes in peri-tumour normal retina following ruthenium-106 and proton beam radiotherapy for uveal melanoma.钌-106 和质子束放射治疗眼黑色素瘤后肿瘤周围正常视网膜的 OCT 变化。
Br J Ophthalmol. 2021 May;105(5):648-652. doi: 10.1136/bjophthalmol-2019-314802. Epub 2020 Jun 25.
2
Blue-Light Fundus Autofluorescence Imaging following Ruthenium-106 Brachytherapy for Choroidal Melanoma.钌-106 近距离放疗后脉络膜黑色素瘤的蓝光眼底自发荧光成像。
Ophthalmologica. 2020;243(4):303-315. doi: 10.1159/000504715. Epub 2020 Jan 15.
3
[Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].[106钌近距离放射治疗脉络膜后极部中小型恶性黑色素瘤的回顾性分析]
Klin Monbl Augenheilkd. 2002 Apr;219(4):216-20. doi: 10.1055/s-2002-30654.
4
Ruthenium-106 plaque brachytherapy for uveal melanoma.钌-106敷贴器近距离放射治疗脉络膜黑色素瘤。
Br J Ophthalmol. 2015 Dec;99(12):1644-9. doi: 10.1136/bjophthalmol-2015-306666. Epub 2015 May 15.
5
Intravitreal aflibercept for the treatment of radiation-induced macular edema after ruthenium 106 plaque radiotherapy for choroidal melanoma.玻璃体内注射阿柏西普治疗脉络膜黑色素瘤经106钌敷贴放疗后放射性黄斑水肿。
Graefes Arch Clin Exp Ophthalmol. 2019 Jul;257(7):1547-1554. doi: 10.1007/s00417-019-04347-6. Epub 2019 May 12.
6
Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.新辅助质子束照射与辅助钌近距离放射治疗在葡萄膜黑色素瘤经巩膜切除术中的比较
Graefes Arch Clin Exp Ophthalmol. 2018 Sep;256(9):1767-1775. doi: 10.1007/s00417-018-4032-7. Epub 2018 Jun 16.
7
Optical coherence tomography angiography-based analysis of intrinsic vasculature in juxtapapillary melanoma after ruthenium-106 plaque brachytherapy.钌-106 放射性敷贴治疗后近瘤周黑色素瘤固有脉管的光相干断层扫描血管造影分析。
Indian J Ophthalmol. 2019 Dec;67(12):2086-2088. doi: 10.4103/ijo.IJO_1928_18.
8
Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.三维预处理建模引导下钌近距离放射治疗中脉络膜黑色素瘤的疗效
Brachytherapy. 2015 Sep-Oct;14(5):718-25. doi: 10.1016/j.brachy.2015.04.010. Epub 2015 Jun 12.
9
Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma.脉络膜黑色素瘤钌板近距离放射治疗的肿瘤控制、眼球保留及视觉效果
Brachytherapy. 2013 May-Jun;12(3):235-9. doi: 10.1016/j.brachy.2012.01.012. Epub 2012 Mar 20.
10
Plaque radiotherapy for the management of uveal metastasis.用于葡萄膜转移瘤治疗的斑块放射疗法。
Arch Ophthalmol. 1997 Feb;115(2):203-9. doi: 10.1001/archopht.1997.01100150205010.

引用本文的文献

1
Efficacy and safety of proton radiotherapy in treating choroidal melanoma: a systematic review and meta-analysis.质子放疗治疗脉络膜黑色素瘤的疗效与安全性:一项系统评价与荟萃分析
Radiat Oncol. 2025 Jan 11;20(1):7. doi: 10.1186/s13014-024-02580-w.